Se nanoparticles (NPs) of predominantly
amorphous phase (α-Se)
have been prepared in room-temperature ionic liquids (RTILs). The
effects of ion-pair combination and −OH functionalization of
RTILs on the size and phase stability of Se NPs were investigated.
The RTILs used were 1-ethyl-3-methyl imidazolium boron tetrafluoride
([EMIM][BF4]), 1-(2-hydroxyethyl)-3-methyl imidazolium
boron tetrafluoride ([EOHMIM][BF4]), and 1-ethyl-3-methyl
imidazolium methane sulfonate ([EMIM][MS]). The size of Se NPs@[EOHMIM][BF4] was found to be the smallest (∼32 nm), followed by
Se NPs@[EMIM][BF4] (∼57 nm) and Se NPs@[EMIM][MS]
(∼60 nm), respectively. Interestingly, the stability studies
revealed minimal size variations for Se NPs@[EMIM][MS], followed by
Se NPs@[EOHMIM][BF4] and Se NPs@[EMIM][BF4],
respectively. The observed trends could be correlated with the strength
of interionic interactions in the respective RTILs, as well as their
packing order (density). Importantly, the RTILs played the role of
a solvent, a stabilizer, and an in situ source of reducing species.
Pulse radiolysis study revealed imidazolium-originated radical species-driven
formation of Se NPs. Further, anticancer efficacy studies demonstrated
the role of NP size, wherein Se NPs@[EOHMIM][BF4] exhibited
the highest cancer cell killing, followed by Se NPs@[EMIM][BF4] and Se NPs@[EMIM][MS]. Another significant highlight of
this work is the reuse of the spent RTILs for the synthesis of the
next batch of Se NPs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.